Bilio-biliary fistula post bile duct injury von Sisco, P.J., Devoto, J.E., Mosna, L., Gianatiempo, M.O., Romay, S., Perrone, N.B.

Volltext

1480OSYMPTOMATIC TOXICITIES EXPERIENCED DURING ANTI-CANCER TREATMENT: COMPARISON OF PATIENTS' AND PHYSICIANS' REPORTING IN THREE RANDOMIZED CONTROLLED TRIALS (RCTS) von Di Maio, M., Piccirillo, M.C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., De Placido, S., Ceribelli, A., Favaretto, A., De Matteis, A., Feld, R., Butts, C.A., Leighl, N.B., Morabito, A., Bryce, J., Signoriello, S., Gallo, C., Perrone, F.

Volltext

1312PTHE RELATIONSHIP BETWEEN EGFR AND KRAS MUTATION STATUS AND OVERALL SURVIVAL (OS) IN THE NCIC CTG BR.26 RANDOMIZED TRIAL OF DACOMITINIB (D) VERSUS PLACEBO (P) IN PATIENTS WITH... von Ellis, P.M., Liu, G., Millward, M., Perrone, F., Shepherd, F., Seymour, L., Sun, S., Cho, B., Morabito, A., Stockler, M.R., Leighl, N.B., Lee, C., Wierzbicki, R., Favaretto, A., Tsao, M., Wilson, C.F., Taylor, I., Ding, K., Goss, G., Bradbury, P.A.

Volltext

Cmet Expression and Activity of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients (Pts): Exploratory Analysis of the Randomized Phase III Torch Trial von Tsao, M., Di Maio, M., Kim, L., Liu, G., Xu, J., Gebbia, V., Burgio, M.A., Alam, Z.Y., Valmadre, G., Higgins, B., Signoriello, S., Rossi, A., Leighl, N.B., Maione, P., Butts, C.A., Ciardiello, F., Feld, R., Gallo, C., Gridelli, C., Perrone, F.

Volltext

Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts) von Di Maio, M., Piccirillo, M.C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., De Placido, S., Ceribelli, A., Favaretto, A., De Matteis, A., Feld, R., Butts, C.A., Leighl, N.B., Morabito, A., Bryce, J., Signoriello, S., Gallo, C., Perrone, F.

Volltext

1249PCMET EXPRESSION AND ACTIVITY OF FIRST-LINE ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): EXPLORATORY ANALYSIS OF THE RANDOMIZED PHASE III TORCH TRIA... von Tsao, M., Di Maio, M., Kim, L., Liu, G., Xu, J., Gebbia, V., Burgio, M.A., Alam, Z.Y., Valmadre, G., Higgins, B., Signoriello, S., Rossi, A., Leighl, N.B., Maione, P., Butts, C.A., Ciardiello, F., Feld, R., Gallo, C., Gridelli, C., Perrone, F.

Volltext

The Relationship Between Egfr and Kras Mutation Status and Overall Survival (Os) in the Ncic Ctg Br.26 Randomized Trial of Dacomitinib (D) Versus Placebo (P) in Patients with Previ... von Ellis, P.M., Liu, G., Millward, M., Perrone, F., Shepherd, F., Seymour, L., Sun, S., Cho, B., Morabito, A., Stockler, M.R., Leighl, N.B., Lee, C., Wierzbicki, R., Favaretto, A., Tsao, M., Wilson, C.F., Taylor, I., Ding, K., Goss, G., Bradbury, P.A.

Volltext